Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Operating Leases (2023 - 2025)

Historic Operating Leases for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $134.0 million.

  • Genmab A's Operating Leases rose 229.01% to $134.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $134.0 million, marking a year-over-year increase of 229.01%. This contributed to the annual value of $134.0 million for FY2025, which is 229.01% up from last year.
  • As of Q4 2025, Genmab A's Operating Leases stood at $134.0 million, which was up 229.01% from $143.0 million recorded in Q1 2025.
  • In the past 5 years, Genmab A's Operating Leases registered a high of $143.0 million during Q1 2025, and its lowest value of $101.0 million during Q4 2023.
  • Over the past 3 years, Genmab A's median Operating Leases value was $132.5 million (recorded in 2024), while the average stood at $127.2 million.
  • In the last 5 years, Genmab A's Operating Leases soared by 2970.3% in 2024 and then soared by 229.01% in 2025.
  • Over the past 3 years, Genmab A's Operating Leases (Quarter) stood at $101.0 million in 2023, then grew by 29.7% to $131.0 million in 2024, then increased by 2.29% to $134.0 million in 2025.
  • Its last three reported values are $134.0 million in Q4 2025, $143.0 million for Q1 2025, and $131.0 million during Q4 2024.